Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Henry Dale wording with Wellcome and Royal Society logos.

Many congratulations to Drs Chris Toepfer and Ladislav Valkovic for being awarded the Sir Henry Dale Fellowship. This prestigious scheme provides support for postdoctoral researchers who aim to become independent scientists leading their own groups, and is a partnership between the Royal Society and the Wellcome Trust.

The title of Dr Toepfer's application was 'Understanding the role of myosin super relaxation in cardiac health and disease', and Dr Valkovic's application was entitled 'Novel multi-nuclear magnetic resonance spectroscopy approaches for the sensitive and robust assessment of human cardiac energetics'. 

Both the researchers now also lead their own research groups, with Dr Valkovic being awarded the University Research Lecturer title last year as well. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

COVID-19 patients continue to experience symptoms six months after infection

Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.